发明名称 |
HEPATOCYTE-TARGETED DRUG CONJUGATES |
摘要 |
The invention provides conjugates for targeting a therapeutic agent to a cell with asialoglycoprotein receptors. The conjugates comprise a therapeutic agent and ligand for the asialoglycoprotein receptor, wherein the therapeutic agent and the ligand are linked by a bridging agent. The bridging agent can be a crosslinker, a polyfunctional carrier molecule or a crosslinker and a polyfunctional carrier molecule. In a preferred embodiment, the therapeutic agent is a nucleoside analog or colchicine and the ligand is asialoorosomucoid, arabinogalactan or a Tris-(N-acetyl galactosamine aminohexyl glycoside) amide of tyrosyl(glutamyl)-glutamate. Preferred crosslinkers include aminoacyl derivatives, carboxyacyl derivatives, phosphate, peptides and reductively-labile crosslinkers. Preferred polyfunctional carrier molecules include polyamino acids and polysaccharides. The conjugates of the invention can be used to target a therapeutic agent to a cell, for example to inhibit viral DNA replication in a virally-infected hepatocyte. |
申请公布号 |
WO9518636(A2) |
申请公布日期 |
1995.07.13 |
申请号 |
WO1995US00448 |
申请日期 |
1995.01.11 |
申请人 |
TARGETECH, INC. |
发明人 |
PLOURDE, ROBERT, JR.;CARMICHAEL, ELLEN;SPITALNY, GEORGE, L.;FINDEIS, MARK, A.;ERNST, MICHAEL, F.;ROBINSON, BRETT |
分类号 |
A61K47/48 |
主分类号 |
A61K47/48 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|